ArticleTechnology in cancer research & treatment

Centenarian Exomes as a Tool for Evaluating the Clinical Relevance of Germline Tumor Suppressor Mutations.

Lubomir Balabanski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.